| http://www.w3.org/ns/prov#value | - The Institute of Medicine (IOM) and ASCO recently studied the array of federal laws such as the Health Insurance Portability and Accountability Act (HIPAA), the regulatory policies administered by CMS officials, and clinical trials oversight by the FDA. Concurrently, the NCI completed an operations analysis of typical clinical trial development.
|
